These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 20822907)
21. A solid-phase approach for the synthesis of muramyl dipeptide conjugates for detection of NOD2. Kekessie I; Goncharov T; Kőműves LG; Vucic D; Song A Bioorg Chem; 2021 Nov; 116():105360. PubMed ID: 34562676 [TBL] [Abstract][Full Text] [Related]
22. NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction. Yang Z; Fuss IJ; Watanabe T; Asano N; Davey MP; Rosenbaum JT; Strober W; Kitani A Gastroenterology; 2007 Nov; 133(5):1510-21. PubMed ID: 17915219 [TBL] [Abstract][Full Text] [Related]
23. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils. Jeong YJ; Kang MJ; Lee SJ; Kim CH; Kim JC; Kim TH; Kim DJ; Kim D; Núñez G; Park JH Immunology; 2014 Oct; 143(2):269-76. PubMed ID: 24766550 [TBL] [Abstract][Full Text] [Related]
24. 17β-Estradiol and progesterone decrease MDP induced NOD2 expression in bovine mammary epithelial cells. Xu DD; Wang G; He XJ; Wang JF; Yang B; Sun ZP; Sun DB; He QY; Zhang X; Wu R Vet Immunol Immunopathol; 2017 Jun; 188():59-64. PubMed ID: 28615128 [TBL] [Abstract][Full Text] [Related]
25. [Synthesis of N-acetyl-muramyl-dipeptide--an immunoadjuvant]. Chen ZY; Chen LF; Gong XQ Yao Xue Xue Bao; 1982 Jun; 17(6):425-30. PubMed ID: 7148465 [No Abstract] [Full Text] [Related]
26. Computational studies on receptor-ligand interactions between novel buffalo (Bubalus bubalis) nucleotide-binding oligomerization domain-containing protein 2 (NOD2) variants and muramyl dipeptide (MDP). Brahma B; Patra MC; Mishra P; De BC; Kumar S; Maharana J; Vats A; Ahlawat S; Datta TK; De S J Mol Graph Model; 2016 Apr; 65():15-26. PubMed ID: 26897084 [TBL] [Abstract][Full Text] [Related]
27. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts. Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140 [TBL] [Abstract][Full Text] [Related]
28. Liposomal preparations of muramyl glycopeptides as immunomodulators and adjuvants. Turánek J; Ledvina M; Kasná A; Vacek A; Hríbalova V; Krejcí J; Miller AD Vaccine; 2006 Apr; 24 Suppl 2():S2-90-1. PubMed ID: 16823942 [TBL] [Abstract][Full Text] [Related]
29. The nucleotide-binding oligomerization domain-containing-2 ligand muramyl dipeptide enhances phagocytosis and intracellular killing of Escherichia coli K1 by Toll-like receptor agonists in microglial cells. Ribes S; Adam N; Schütze S; Regen T; Redlich S; Janova H; Borisch A; Hanisch UK; Nau R J Neuroimmunol; 2012 Nov; 252(1-2):16-23. PubMed ID: 22889567 [TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of muramyl peptides by NAGK is required for NOD2 activation. Stafford CA; Gassauer AM; de Oliveira Mann CC; Tanzer MC; Fessler E; Wefers B; Nagl D; Kuut G; Sulek K; Vasilopoulou C; Schwojer SJ; Wiest A; Pfautsch MK; Wurst W; Yabal M; Fröhlich T; Mann M; Gisch N; Jae LT; Hornung V Nature; 2022 Sep; 609(7927):590-596. PubMed ID: 36002575 [TBL] [Abstract][Full Text] [Related]
31. Potential adjuvants for synthetic vaccines. I. Modulators of macrophage activation. Solange A Chem Phys Lipids; 1995 Jan; 75(1):51-8. PubMed ID: 7697782 [TBL] [Abstract][Full Text] [Related]